The 2026 Sabin Awards were presented yesterday at the National Academy of Sciences building in Washington, D.C., honoring notable vaccine researchers. Professor Uğur Şahin, MD, and Professor Özlem Türeci, MD, received the Sabin Vaccine Institute's Albert B. Sabin Gold Medal for their pivotal role in turning the tide of the COVID-19 pandemic and their ongoing efforts to support access to novel medicines globally. Dr. Senjuti Saha of Bangladesh was awarded the 2026 Rising Star Award for using genomics to inform the rollout of the world's largest typhoid vaccine program, protecting millions of children.
Gold Medal Recipients
Together, Professors Şahin and Türeci have helped reshape the future of vaccines, demonstrating how scientific entrepreneurship can translate cutting-edge research into global public health impact. The Sabin Gold Medal recognizes their extraordinary contribution to accelerating lifesaving vaccines and their commitment to vaccine access and equity.
Professors Şahin and Türeci, who are both business and life partners, were awarded the Sabin Gold Medal for their steadfast dedication to supporting medicine access through innovative technologies they have been pioneering for decades. At the onset of the COVID-19 pandemic, they leveraged the technology they had been researching and developing for decades, originally for oncology applications, and pivoted their company's focus to develop a COVID-19 vaccine in record time that helped protect billions of lives.
Driven by the mission to improve the health of people worldwide, Şahin and Türeci continue to advance the development of vaccine candidates against diseases of major relevance to millions of people worldwide, including tuberculosis, HIV, and malaria. Their dedication extends beyond developing medical innovations as they work along the entire R&D chain to make a difference for communities. Together with their team and partners, they are leading efforts to contribute to building a sustainable and resilient vaccine ecosystem in Africa, for Africa.
We are deeply honored to receive the 2026 Sabin Gold Medal. Albert Sabin's conviction that scientific breakthroughs only truly matter when they reach the people has been a lasting source of inspiration for us. We firmly believe that innovative medicines must be accessible to those who need them most. This award is a testament to a collaborative effort, recognizing the dedication of our teams and partners around the world who walk this journey with us and share a deep sense of commitment to improving health.
Rising Star Award
Sabin's Rising Star Award encourages and recognizes the next generation of vaccine and immunization leaders. Rising Star Awardee Dr. Senjuti Saha generates critical evidence for major national immunization initiatives, including Bangladesh's 2025 typhoid conjugate vaccine campaign that has already reached more than 40 million children. As Deputy Executive Director of the Child Health Research Foundation (CHRF), she helped build one of the country's leading genomic laboratories. The lab has sequenced thousands of pathogen genomes to improve outbreak detection and inform vaccine development for diseases such as Klebsiella and RSV. Her work also emphasizes developing local scientific leadership and mentoring the next generation of researchers.
